International Stem Cell Corporation Announces Commencement of Enrollment of Phase I Trial of ISC-hpNSC
07 mars 2016 08h30 HE
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - March 07, 2016) - International Stem Cell Corporation (OTCQB: ISCO), a clinical stage biotechnology company developing novel stem cell-based therapies, announced...
International Stem Cell Corporation Signed a Clinical Service Agreement With the Florey Institute of Neuroscience and Mental Health
23 déc. 2015 08h30 HE
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - December 23, 2015) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) a clinical stage biotechnology company developing novel stem...
International Stem Cell Corporation Receives Authorization to Initiate Phase I/IIa Clinical Trial of ISC-hpNSC for the Treatment of Parkinson's Disease
14 déc. 2015 08h30 HE
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - December 14, 2015) - International Stem Cell Corporation (OTCQB: ISCO), a leader in using pluripotent stem cells in regenerative medicine, announced today that the...
International Stem Cell Corporation Announces Launch Plans for New Nano-Compound Products
01 déc. 2015 08h30 HE
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - December 01, 2015) - International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell-based therapies and biomedical...
International Stem Cell Corporation Announces Operating Results for the Three- and Nine-Months Ended September 30, 2015
16 nov. 2015 08h30 HE
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - November 16, 2015) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based biotechnology company...
International Stem Cell Corporation Moves Forward With Parkinson's Disease Clinical Trials in Australia
03 nov. 2015 08h30 HE
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - November 03, 2015) - International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell-based therapies and biomedical...
International Stem Cell Corporation Presents Comprehensive Findings for Parkinson's Disease Program Preclinical Studies at the Society for Neuroscience Annual Meeting, Neuroscience 2015
14 oct. 2015 08h30 HE
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - October 14, 2015) - International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell-based therapies and biomedical...
International Stem Cell Corporation Develops Technology to Replace Cartilage for the Treatment of Osteoarthritis
30 sept. 2015 08h30 HE
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - September 30, 2015) - International Stem Cell Corporation (OTCQB: ISCO)(www.internationalstemcell.com, ISCO or the Company), a California-based biotechnology company...
International Stem Cell Names Ms. Ebrahimi as Chief Financial Officer
22 sept. 2015 08h30 HE
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - September 22, 2015) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com, ISCO or the Company), a California-based biotechnology company...
International Stem Cell Corporation Announces Next Phase of Research Collaboration With Rohto Pharmaceutical Co., Ltd. of Japan
08 sept. 2015 08h30 HE
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - September 08, 2015) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com, ISCO or the Company), a California-based biotechnology company...